PCT, a Hitachi Group Company, is a leading development and manufacturing partner to the global cell therapy industry. PCT’s mission is to provide its clients with high quality, scalable, innovative, reliable and cost-efficient manufacturing platforms and services to advance commercialization of cell therapies. PCT’s vision is a world in which transformative cell-based therapeutics are accessible to all. With proven expertise and more than 18 years of experience, PCT supports the advancement of its clients’ life-changing medical treatments by mitigating the risks of product development and providing efficient, custom manufacturing solutions to advance clinical development programs through to commercialization.In May 2017, Hitachi Chemical Co. America, Ltd. competed its acquisition of PCT. With this acquisition, PCT became an independent business unit focused on cell therapy and regenerative medicine within the life sciences division of Hitachi Chemical. As a part of Hitachi Chemical, PCT will be able to expand manufacturing capacity, capabilities and service offerings to more effectively and efficiently meet the needs of our clients anywhere in the world.
For more information, visit www.pctcelltherapy.com